Evaluation
*
*
Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly agree
12345
Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics.
Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis.
*
*
Please use the scale: 1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident
12345
Your ability to identify and address treatment barriers when managing patients with multiple sclerosis?
Your understanding of the science of B-cell targeted therapy in multiple sclerosis?
*
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me
12345N/A
Communicate treatment barriers to patients and develop personalized treatment plans.
Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies.
*